Nanotechnology has emerged as a revolutionary frontier in pharmaceuticals, particularly in the realm of diagnosis. This cutting-edge technology involves manipulating materials at the nanoscale, typically ranging from 1 to 100 nanometers, to create novel structures and devices with unique properties. In the pharmaceutical sector, nanotechnology holds immense promise for diagnostic applications. Nanoscale materials can be engineered to interact with biological systems in highly specific ways, enabling the development of advanced diagnostic tools with unprecedented precision.
Nanoparticles, for instance, can be functionalized with targeting ligands to selectively bind to specific biomarkers associated with diseases. This targeted approach enhances the sensitivity and accuracy of diagnostic tests, allowing for early and more reliable detection of various medical conditions. Furthermore, nanoscale diagnostic agents can be designed to traverse biological barriers, enabling non-invasive imaging and detection at the molecular level. As nanotechnology continues to advance, its integration into pharmaceutical diagnostics is poised to revolutionize the field, offering more effective and personalized diagnostic solutions for improved patient outcomes.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation